Toxicokinetics and Physiologically Based Toxicokinetics in Toxicology and Risk Assessment

References

• Abelson , P. H. 1990 . Testing of carcinogens with rodents . Science , 249 : 1387
   Web of Science ®Google Scholar
• Ames , B. N. and Gold , L. S. 1990 . Chemical carcinogenesis: Too many rodent carcinogens . Poct Natl Acad Sci USA , 87 : 7772 – 7776 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. , Gentry , P. R. , Gearhart , J. M. , Allen , B. C. and Andersen , M. E. 1995 . Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene . Chemosphere , 31 : 2561 – 2578 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. , Gentry , R. , Gearhart , J. M. , Allen , B. C. and Andersen , M. E. 2001 . Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model . Science of the Total Environment. , 274 : 37 – 66 .
   PubMed Web of Science ®Google Scholar
• Counts , J. and Goodman , J. 1995 . Principles underlying dose selection for, and extrapolation from the carcinogen bioassay: Dose influence mechanism . Regul. Toxicol. Pharmacol. , 21 : 418 – 421 .
   PubMed Web of Science ®Google Scholar
• Davies , B. and Morris , T. 1993 . Physiological parameters in laboratory animals and humans . Pharm Res. , 10 : 1093 – 1095 .
   PubMed Web of Science ®Google Scholar
• Feron , V. J. , Hendriksen , C. F. M. and Speek , A. J. 1981 . Lifespan oral toxicity study of vinyl chloride in rats . Food Cosmet. Toxicol. , 19 : 317 – 333 .
   PubMedGoogle Scholar
• Frederick , C. , Bush , M. L. , Subramaniam , R. P. , Black , K. A. , Finch , L. , Kimbell , J. S. , Morgan , K. T. , Subramaniam , R. P. , Morris , J. B. and Ultaman , J. S. 1998 . Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways . Toxicol. Appl. Pharmacol. , 152 : 211 – 231 .
   PubMed Web of Science ®Google Scholar
• Haddad , S. , Pelekis , M. and Krishnan , K. 1996 . A methodology for solving physiologically based pharmacokinetic models without the use of stimulation software . Toxicol Lett. , 85 : 113 – 126 .
   PubMed Web of Science ®Google Scholar
• Haseman , J. K. and Lockhart , A. 1994 . The relationship between use of maximum tolerated dose an study sensitivity for detecting rodent carcinogenicity . Fundam. Appl. Toxicol. , 22 : 382 – 391 .
   PubMedGoogle Scholar
• Kohn , M. C. , Lucier , G. W. , Clark , G. C. , Sewall , C. , Tritscher , A. and Portier , C. J. 1993 . A mechanistic model of the effect of dioxin on gene expression in the rat liver . Toxicol. Appl. Pharmacol. , 120 : 138 – 154 .
   PubMed Web of Science ®Google Scholar
• Mahmood , I. and Balian . 1999 . The pharmacokinetic principles behind scaling from preclinical results to phase 1 protocols . Clin. Pharmacokinet. , 36 : 1 – 11 .
   PubMed Web of Science ®Google Scholar
• Maltoni , C. , Lefemine , G. , Ciliberti , A. , Cott , G. and Caretti , D. 1981 . Carcinogencity bioassay of vinyl chloride monomer: A model of risk assessment on an experimental basis . Environ. Health Perspect. , 41 : 3 – 29 .
   PubMed Web of Science ®Google Scholar
• Maltoni , C. , Lefemine , G. , Ciliberti , A. , Cotti , G. and Caretti , D. 1984 . “ Experimental research on vinyl chloride carcinogeneis ” . In Archives of research on industrial carcinogenesis , Edited by: Maltoni , C. and Mehlman , M. A. Vol. 2 , Princeton, NJ : Princeton Scientific .
   Google Scholar
• McConnell , E. E. 1989 . The maximum tolerated dose: The debate . J. Am. Coll. Toxicol. , 8 : 1115 – 1120 .
   Google Scholar
• Morris , J. B. , Hassett , D. N. and Blanchard , K. T. 1993 . A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors . Toxicol Appl. Pharmacol. , 123 : 120 – 129 .
   PubMed Web of Science ®Google Scholar
• Monro , A. 1994 . Drug toxicokinetics: Scope and limitations that arise from species differences in pharmacodynamic and carcinogenesis response . J Pharmacokinet. Biopharm. , 12 : 41 – 57 .
   Google Scholar
• Mortensen , B. and Nilsen , O. G. 1998 . Allometric species comparison to toluene and n-hexane metabolism: Prediction of hepatic clearance in man from experiments with rodent liver S9 in a head space vial equilibration system . Pharmacol. Toxicol. , 82 : 183 – 188 .
   PubMedGoogle Scholar
• National Research Council. 1986. Drinking water and health. vol 6. chap. 6. Washington, DC: National Academy Press.
   Google Scholar
• Occupational Safety and Health Administration . 1997 . Occupational exposure to methylene chloride; final rule . Fed. Reg. , 62 ( 7 ) : 1493 – 1619 .
   Google Scholar
• Poulin , P. and Krishnan , K. 1996 . Molecular structure-based prediction of the partition coefficients of organic chemicals for physiological pharmacokinetic models . Toxicol. Methods. , 6 : 117 – 137 .
   Web of Science ®Google Scholar
• Renwick , A. G. 1994 . “ Toxicokinetics-pharmacokinetics ” . In Priniciples and methods of toxicology , 3rd edit. , Edited by: Hayes , A. W. 101 – 147 . New York : Raven Press .
   Google Scholar
• Riviere , J. E. 1999 . Comparative pharmacokinetics: Principles techniques and applications , Ames : Iowa State University Press .
   Google Scholar
• Rowland , M. and Tozer , T. N. 1995 . Clinical pharmacokinetics: Concepts and applications , 3rd , Philadelphia : Lea and Febiger .
   Google Scholar
• Simonato , L. , L'Abbe , K. A. , Andersen , A. , Belli , S. , Comba , P. , Engholm , G. , Ferro , G. , Hagmer , L. , Langard , S. , Lundberg , I. , Pirastu , R. , Thomas , P. , Winkelmann , R. and Saracci , R. 1991 . A collaborative study of cancer incidence and mortality among vinyl chloride workers . Scand J Works Environ Health , 17 : 159 – 169 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. 1991 . Physiological modelling of organic compounds . Ann Occup. Med , 35 : 305 – 321 .
   Google Scholar
• Andersen , M. E. , Clewell , H. J. III , Gargas , M. L. , Smith , F. A. and Reitz , R. H. 1987 . Physiologically-based pharmacokinetics and the risk assessment process for methylene chloride . Toxicol. Appl. Pharmacol. , 87 : 185 – 205 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Mills , J. J. , Gargas , M. L. , Kedderis , L. , Birnbaum , L. S. , Neubert , D. and Greenlee , W. F. 1993 . Modeling receptor-mediated process with dioxin: Implications for pharmacokinetics and risk assessment . J Risk Anal. , 13 : 25 – 36 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Birnbaum , L. S. , Barton , H. A. and Eklund , C. 1997 . Regional hepatic CYPIA1 and CYPA2 and induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluted with a multi-compartment geometric model of hepatic zonation . Toxicol. Appl. Pharmcaol , 144 : 145 – 155 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Sarangapani , R. , Frederick , C. B. and Kimbell , J. S. 1999 . Dosimetric Adjustment factors for methymethacrylate derived from a steady-state analysis of a physiologically based clearance . extraction model. Inhal. Toxicol. , 11 : 899 – 926 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Sarangapani , R. , Gentry , P. R. , Clewell , H. J. III. , Covington , T. R. and Frederick , C. B. 2000 . Application of a hybrid CFD-PBPK nasal dosimetry in an inhalation risk assessment: An example with acrylic acid . Toxicol. Sci. , 57 : 312 – 325 .
   PubMed Web of Science ®Google Scholar
• Arms, A. D., and Travis, C. C. 1988. Physiology parameters in pharmacokinetic modelling. EPA/600/6-88/004,1-1-7-16. Washington DC: Office of Health and Environmental Assessment, U. S. EPA.
   Google Scholar
• Bachmann , K. , Pardoe , D. and White , D . 1996 . Scaling basic toxicokinetic parameters from rat to man . Environ Health Perspect. , 104 : 400 – 407 .
   PubMed Web of Science ®Google Scholar
• Benet, L. Z., and Sceiner, L. B. 1985. In The pharmacological basis of therapeutics, eds. A. G. Gilman, L. S. Goodman, T. W. Rall and F, Murad, 7th ed. New York: Macmillan.
   Google Scholar
• Bogdanffy , M. S. , Sarangapani , R. , Plowchalk , D. R. , Jarabek , A and Andersen , M. E. 1999 . A biologically-based risk assessment for vinyl acetate-induced cancer and non-cancer inhalation toxicity . Toxicol. Sci. , 51 : 19 – 35 .
   PubMed Web of Science ®Google Scholar
• Bourne , D. W. A. 1995 . Mathematical modelling of pharmacokinetic data , Lancaster. PA : Technomic .
   Google Scholar
• Brown , R. P. , Delp , M. D. , Lindstedt , S. L. , Rhomberg , L. R. and Beliles , R. P. 1997 . Physiological parameter values for physiologically based pharamacokinetic models . Toxicol. Ind. Health , 13 : 407 – 484 .
   PubMed Web of Science ®Google Scholar
• Caines , P. E. 1988 . Linear stochastic system , New York : Wiley and Sons .
   Google Scholar
• Caldwell , J. 1992 . Problems and opportunities in toxicity testing arising from species difference in xenobiotic metabolism . Toxicol Lett. , 64/65 : 651 – 659 .
   Web of Science ®Google Scholar
• Chemical Industry Institute of Toxicology . 1999 . Formaldehyde: Hazard characterization and dose-response assessment for carcinogenicity by the route on inhalation , Research Triangle Park, NC : CIIT .
   Google Scholar
• Chen , C. W. and Blancato , J. N. 1989 . Incorporation of biological information in cancer risk assessment: Example-Vinyl chloride . Cell Biol. Toxicol. , 5 : 417 – 444 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III. and Andersen , M. E. 1985 . Risk assessment extrapolation and physiological modeling . Toxicol. Ind. Health , 1 : 111 – 131 .
   PubMedGoogle Scholar
• Clewell , H. J III and Andersen , M. E. 1987 . Dose, species and route extrapolation using physiologically based pharmacokinetic models . Drinking Water Health , 8 : 159 – 182 .
   Google Scholar
• Smith , D. A. 1990 . Design of toxicokinetic studies . Xenobiotica , 20 : 1187 – 1199 .
   PubMed Web of Science ®Google Scholar
• Tritscher , A. M. , Goldstein , J. A. , Portier , C. J. , McCoy , Z. , Clark , G. C. and Lucier , G. W. 1992 . Doseresponse relationships for chronic exposure to 2,3,7,8-tetrchlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYPIA1 and CYPIA2 in the liver . Cancer Res , 52 : 3436 – 3442 .
   PubMed Web of Science ®Google Scholar
• U. S. Environmental Protection Agency. 1994. Methods for derivation of inhaled reference concentrations and application of inhalation dosimerty. EPA/600/8-90/066F. Washington, DC: Office of Research and Development.
   Google Scholar
• U. S. Environmental Protection Agency. 1996. Proposed guildelines for carcinogen risk assessment. EPA/600/P-92/003C. Washington DC: Office of Research and development.
   Google Scholar
• U. S. Environmental Protection Agency. (2000a). Toxicological review of vinyl chloride. Appendices A-D. EPA/635R-00/004.
   Google Scholar
• U. S. Environmental Protection Agency. (2000b). Exposure and human reassessment of 2,3,7,8-tetrachlorodibenzo-o-dioxin (TCDD) and related compounds. Part II. In Health assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds, chap. 8. Dose-response modeling for 2,3,7,8-TCDD, NCEA-1-0835. May. Science Advisory Board Review Draft.
   Google Scholar
• Voisin , E. , Ruthsatz , M. , Collins , J. M. and Hoyle , P. C. 1990 . Extrapolation of animal toxicity to humans: Interspecies comparisons in drug development . Regual. Toxicol. Pharmacol. , 12 : 107 – 116 .
   PubMed Web of Science ®Google Scholar
• Welling, P. G., and de la Igelsia F. A., eds. 1993. Drug toxicokinetics. New York: Marcel Dekker.
   Google Scholar
• Fox , A. J. and Collier , P. F. 1977 . Mortality experience of workers exposure to vinyl chloride monomer in the manufacture of polyvinyl chloride in Great Britain . Br. J Ind. Med. , 34 : 1 – 10 .
   PubMedGoogle Scholar
• Gabrielsson , J. and Weiner , D. 1997 . Pharmacokinetic/pharmacodynamic data analysis: Concepts and applications , 2nd , Stockholm : Apotekarsocieteten .
   Google Scholar
• Gelman , A. , Bois , F. and Jiang , J. 1996 . Physiological pharmackinetic analysis using population modeling and informative prior distributions . J Am. Stat Assoc. , 91 : 1400 – 1412 .
   Web of Science ®Google Scholar
• Gerlowski , L. E. and Jain , R. K. 1983 . Physiologically based pharmacokinetic modeling: Principles and applications . J Pharm Sci. , 72 : 1103 – 1127 .
   PubMed Web of Science ®Google Scholar
• Gibaldi , M. and Perrier , D. 1982 . Pharmacokinetics , 2nd , New York : Marcel Dekker .
   Google Scholar
• Haddad , S. , Withey , J. R. , Laparé , S , Law , F. C. P. and Krishnan , K. 1988 . Physiological-based pharmacokinetic modeling of pyrene in the rat . Environ Toxicol. Pharmacol. , 5 : 245 – 255 .
   Web of Science ®Google Scholar
• Health Canada . 1993 . Canadian Environmental Protection Act. Priority substances list assessment report Dichloromethane , Ottawa , , Canada : Canada Communication Group .
   Google Scholar
• ICH. 1995a . Guidelines on assessment of systemic exposure in toxicity studies . Fed Reg. , 60 ( 40 ) : 11264 – 11268 .
   Google Scholar
• ICH. 1995b . Guidelines on dose selection for carcinogenicity studies of pharmaceuticals . Fed Reg. , 60 ( 40 ) : 11278 – 11281 .
   Google Scholar
• ICH. 1995c . Guildelines on repeated dose tissue distribution studies . Fed Reg. , 60 ( 40 ) : 11274 – 11275 .
   Google Scholar
• International Life Sciences Institute. 1977. An evaluation of EPA's proposed guidelines for carcinogen risk assessment using chloroform and dichloroacetic acid as case studies: Report of an expert panel. Washington, DC: International life Sciences Institute, Health and Environmental Sciences Institute.
   Google Scholar
• Clewell, H. J. III, Andersen, M. E., Wills, R. J. Wills and Latriano L. 1997. A physiologically based pharmacokinetic model for retinoic acid and its metabolities. J Am Acad Dermatol. 36:S77-S85.
   Google Scholar
• Contrera , I. F. , Jacobs , A. C. , Prasanna , H. R. , Mehta , M. , Schmidt , W. J. and De George , J. 1995 . A systemic exposure based alternative to the maximum tolerated dose for carcinogenicity studies of human therapeutics . J Am. Colf. Toxicol. , 14 : 1 – 10 .
   Web of Science ®Google Scholar
• DeGeorge , J. 1995 . Food and Drug Administration's viewpoint on toxicokinetics . The view from review. Toxicol Pathology , 23 : 220 – 225 .
   PubMed Web of Science ®Google Scholar
• Effect of dose and time in a long-term, low dose carcinogenicity study. J Environ Pathol Toxicol. 8: 17-34.
   Google Scholar
• Environmental Protection Agency (EPA), Methods for Derivation of Inhalation Reference Concentarations and Application of Inhalation Dosimetry, EPA/600/8-90/066F (Office of Health and Environmental Assessment, Washington, D. C., 1994).
   Google Scholar
• Federal Register. 1996. Part II Environmental Protection Agency. 40CFR 799. Proposed test rule for hazardous air pollutants; Proposed Rule. Fed Reg. June 26, 1996. 33177-3320.
   Google Scholar
• Iwatsubo , T. , Suzuki , H. and Sugiyama , Y. 1977 . Prediction of species differences (rat, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data . J. Pharmacol. Exp. Ther. , 283 : 462 – 469 .
   Google Scholar
• Jones , R. W. , Smith , D. M. and Thomas , P. G. 1988 . A mortality study of vinyl chloride monomer workers employed in the United Kingdom in 1940B1974 . Scand J Work Environ. Health , 14 : 153 – 160 .
   PubMed Web of Science ®Google Scholar
• Kedderis , G. L. and Held , S. D. 1996 . Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats. mice, and humans . Toxicol Appl. Pharmacol. , 140 : 124 – 130 .
   PubMed Web of Science ®Google Scholar
• Krishnan , K. and Andersen , M. E. 2001 . “ Physiologically based pharmacokinetic modeling in toxicology ” . In Principles and methods of toxicology , Edited by: Hayes , A. W. 193 – 241 . Philadelphia : Taylor & Francis .
   Google Scholar
• Krishnan , K. , Gargas , M. L. and Andersen. , M. E. 1993 . In vitro toxicology and risk assessment . Alt. Methods Toxicol. , 9 : 185 – 203 .
   Google Scholar
• Leung , H. W. 1991 . Development and utilization of physiologically based pharmacokinetic models for toxicological applications . J Toxicol Environ. Health , 32 : 247 – 267 .
   PubMed Web of Science ®Google Scholar
• Littlefield , N. A. , Farmer , J. H. and Gaylor , D. W. 1979 . Effect of dose and time in a long-term, low dose carcinogenicity study . J Environ Pathol. Toxicol. , 8 : 17 – 34 .
   Google Scholar
• Lipscomb , J. C. , Fisher , J. W. , Confer , P. D. and Byczkowski , J. Z. 1988 . In vitro to in vivo extrapolation for trichloroethylene metabolism in humans . Toxicol. Appl. Pharmacol. , 152 : 376 – 387 .
   Web of Science ®Google Scholar
• Plowchalk , D. R. , Andersen , M. E. and Bogdanffy , M. S. 1997 . Physiologically-based modeling of vinyl acetate uptake, metabolism and intracellular pH changes in the rat nasal cavity . Toxicol. Appl. Pharmacol. , 142 : 386 – 400 .
   PubMed Web of Science ®Google Scholar
• Poulin , P. and Krishnan , K. 1999 . Molecular structure-based prediction of the toxicokinetics of inhaled vapors in humans . Int. J Toxicol , 18 : 7 – 18 .
   Web of Science ®Google Scholar
• Reitz , R. H. , Cargas , M. L. , Andersen , M. E. , Provan , W. M. and Green , J. L. 1996 . Predicting cancer risk form vinyl chloride exposure with a physiologically based pharmacokinetic model . Toxicol. Appl. Pharmacol. , 137 : 253 – 267 .
   PubMed Web of Science ®Google Scholar